Downregulation of melanogenesis: drug discovery and therapeutic options.

Pillaiyar, Thanigaimalai; Manickam, Manoj; Jung, Sang-Hun

Pillaiyar, Thanigaimalai; Manickam, Manoj; Jung, Sang-Hun.

Affiliation

Pillaiyar T; PharmaCenter Bonn, Pharmaceutical Institute, Pharmaceutical Chemistry I, University of Bonn, An der Immenburg 4, D-53121 Bonn, Germany. Electronic address: thanigai@uni-bonn.de.
Manickam M; College of Pharmacy and Institute of Drug Research and Development, Chungnam National University, Daejeon 34134, South Korea.
Jung SH; College of Pharmacy and Institute of Drug Research and Development, Chungnam National University, Daejeon 34134, South Korea.

Drug Discov Today ; 22(2): 282-298, 2017 02.

Article in En | MEDLINE | ID: mdl-27693716

Subject(s)

Melanins/antagonists & inhibitors; Melanins/metabolism; Monophenol Monooxygenase/antagonists & inhibitors; Animals; Autophagy; Copper-Transporting ATPases/metabolism; Down-Regulation; Drug Discovery; Humans; Microphthalmia-Associated Transcription Factor/metabolism; Mitogen-Activated Protein Kinases/metabolism; Monophenol Monooxygenase/metabolism; Nitric Oxide/antagonists & inhibitors; Signal Transduction; Wnt Signaling Pathway

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Monophenol Monooxygenase / Melanins Limits: Animals / Humans Language: En Journal: Drug Discov Today Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2017 Document type: Article Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google